Plumb
C-

Cannabis discovery marketplace and dispensary/strain directory with user reviews

Leafly

Leafly Holdings, Inc. (Nasdaq/OTC: LFLY); formerly owned by Privateer Holdings

Marketplace Free to read Visit Leafly ↗

A useful weed-shopping directory whose listings and placement are bought by the very dispensaries it ranks, with reviews that are crowd opinion rather than testing, so treat its prominence and strain data as marketing, not a verdict.

What it's really for A cannabis discovery platform and dispensary marketplace; dispensaries pay for listings and ads, and it earns on orders.

What our grade covers The grade on this page is about its strain and dispensary reviews and ratings, not everything the site does.

High Scoring Confidence Checked against primary sources. We are confident in the facts and the grade here.

Follow the money

Leafly is paid almost entirely by the cannabis retailers and brands it lists, not by consumers. Per its own advertiser materials and SEC-reported results, dispensaries pay for listings, online-ordering tools and advertising, and can buy "Platinum Placement" boosts; by Leafly's own marketing, paying for ads and placement increases a business's visibility and position in the directory, so spend influences prominence even though organic user star ratings are tracked separately.

Source →
Operating since
2010 (16 years) · source
What it costs you
Free to read The reviews are free to read.
How they make money
Two-sided cannabis marketplace. Revenue comes overwhelmingly from the businesses it lists: paid dispensary listing subscriptions, online-ordering/menu SaaS, and display advertising (sold on cost-per-impression), plus brand advertising. In Q3 2024 retail (dispensary) revenue was roughly 88% of total, from about 3,554 paying retail accounts at an average ~$695/month. Total revenue was about $34.6M in 2024, down from ~$42.3M in 2023.
What they do
Leafly runs a large cannabis discovery site combining a strain/product database, user-written star reviews of strains, products and dispensaries, and a directory where shoppers browse local dispensary menus and place pickup/delivery orders.
What to watch for
The directory and "best of" surfacing are shaped by who pays: dispensaries buy listing subscriptions, ads and placement boosts ("Platinum Placement"), so high visibility reflects spend as much as quality. Strain reviews are crowd-sourced opinion, not lab testing, and Leafly itself cautions that strain names and data are inconsistent and unverified.
Composite score
2.10 / 5.00 → grade C-

How the grade was reached

Independence · 30% weight 2 / 5

Does the site take money from the very entities it ranks? Pay-for-placement, vendor-funded data, and affiliate commissions all pull this down. The less the ranking can be bought, the higher the score.

Evidence basis · 30% weight 2 / 5

What is the ranking actually built on? Hands-on testing scores highest, then verified first-hand reviews, then opinion or popularity surveys and self-reported figures, then pay-to-rank, which scores lowest.

Method transparency · 20% weight 2 / 5

Is the methodology published, specific, and reproducible? Can a reader see how a given rank was reached, or is it a black box?

Conflict disclosure · 10% weight 3 / 5

Are commercial relationships, sponsorships, and affiliate arrangements disclosed clearly and near the rankings themselves, rather than buried?

Manipulation resistance · 10% weight 2 / 5

How hard is it to game? Controls against fake reviews, solicited reviews, and vendor gaming raise this; an open box anyone can stuff lowers it.

Evidence

Compare with others

Others reviewing cannabis (compare all →)

← Back to the Report Card